Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algamar is a pioneering Spanish marine biotechnology company specializing in the harvesting, processing, and research of edible Atlantic seaweed. Founded in 1996 and headquartered in Galicia, the company is a leader in the European organic seaweed market, offering a diverse range of seaweed-based food products and functional ingredients. Algamar maintains a strong focus on R&D, collaborating with scientific institutions to investigate the health benefits and bioactive properties of marine algae, such as their antioxidant and nutritional profiles. The company is committed to sustainable harvesting practices and utilizes specialized dehydration technology to preserve the biological integrity of its products. Algamar's offerings cater to the health, wellness, and functional food sectors, positioning it as a key player in the marine-based nutraceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algamar.